Easily stay on top of the latest nutrition research
Become an Examine Member to get access to the latest research. Get 150+ studies summarized for you across 25 different categories every month.
Members also have access to the Examine Study Database of 400+ supplements and their effects on 600+ health outcomes, as well as in-depth research analyses. Understand the whole body of nutrition and supplement evidence at a glance.
Get instant access — start your free 14-day trialAlready a Member? Click here to log in.
The Human Effect Matrix looks at human studies to tell you what supplements affect Non-HDL Cholesterol.
Unlock the full Study Database with an Examine Membership. Get a 14-day free trial.
| Grade | Level of Evidence [show legend] |
|---|---|
|
Robust research conducted with repeated double-blind clinical trials |
|
Multiple studies where at least two are double-blind and placebo controlled |
|
Single double-blind study or multiple cohort studies |
|
Uncontrolled or observational studies only |
|
Level of Evidence
?
The amount of high quality evidence. The more
evidence, the more we can trust the results.
|
Supplement |
Magnitude of effect
?
The direction and size of the supplement's impact on
each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
|
Consistency of research results
?
Scientific research does not always agree. HIGH or
VERY HIGH means that most of the scientific research agrees.
|
Notes |
|---|---|---|---|---|
|
|
Notable
|
Very High See 2 studies |
The two studies which measured this both found a decrease in the kefir group, but evidence is mixed on whether the effect is caused by other dairy: One study saw the same reduction in its milk group, the other didn't see this reduction in its yogurt group.
|
|
|
|
Notable
|
- See study |
According to a systematic review and meta-analysis of 112 randomized controlled trials, plant protein in substitution for animal protein can decrease non-HDL cholesterol by -0.18 mmol/L (95% confidence interval, -0.22 to -0.14 mmol/L; P<0.00001; I2=52%; moderate-quality evidence)
|
|
|
|
- | - See study |
|
